Cynapsus is a specialty pharmaceutical company developing a convenient and easy-to-use sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease. More than 1 million people in the U.S. and an estimated 4 to 6 million people globally suffer from Parkinson's disease. Parkinson’s disease is a chronic and progressive neurodegenerative disease that impacts motor activity, and its prevalence is increasing with the aging of the population. OFF episodes are a complication of Parkinson’s disease that leave patients rigid and unable to move and communicate.

Horizonatal Rule
About CynapsusLine SeperationValue PropositionLine SeperationAPL-130277 ProductLine SeperationInvestor RelationsLine SeperationContact & LegalLine Seperation

Copyright 2014, Cynapsus Therapeutics Inc.
All rights reserved.

Traded on